These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Parés A; Cisneros L; Salmerón JM; Caballería L; Mas A; Torras A; Rodés J Am J Gastroenterol; 2004 Jun; 99(6):1105-10. PubMed ID: 15180733 [TBL] [Abstract][Full Text] [Related]
6. Treatment of intra-heptic cholestasis in primary biliary cirrhosis by long term plasmapheresis. Vankeerberghen L; Oppenheimer M; Opolon P; Lévy VG Life Support Syst; 1983; 1 Suppl 1():106-11. PubMed ID: 6443835 [TBL] [Abstract][Full Text] [Related]
7. D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives. Matloff DS; Kaplan MM Gastroenterology; 1980 May; 78(5 Pt 1):1046-9. PubMed ID: 7380177 [TBL] [Abstract][Full Text] [Related]
8. Role of plasmapheresis in primary biliary cirrhosis. Cohen LB; Ambinder EP; Wolke AM; Field SP; Schaffner F Gut; 1985 Mar; 26(3):291-4. PubMed ID: 3972276 [TBL] [Abstract][Full Text] [Related]
9. Twenty-six years of plasma exchange for symptomatic treatment of pruritus in primary biliary cirrhosis. Axelsson CG; Hallbäck DA Transfus Apher Sci; 2013 Dec; 49(3):652-4. PubMed ID: 23899960 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasmapheresis for cholestatic liver diseases: study of 9 cases. Omokawa S; Yamashita M; Malchesky PS; Koo AP; Matsushita M; Nosè Y Prog Clin Biol Res; 1990; 337():233-6. PubMed ID: 2352983 [No Abstract] [Full Text] [Related]
11. [Primary biliary cirrhosis: therapeutic trial using plasma exchange and immunosuppression. Preliminary results]. Rifle G; Mousson C; Hillon P; Marceau M; Chalopin JM; Tanter Y Ann Med Interne (Paris); 1988; 139 Suppl 1():32-4. PubMed ID: 3247987 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis]. Renner EL Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985 [TBL] [Abstract][Full Text] [Related]
15. [Association of scleroderma with primary biliary cirrhosis (author's transl)]. Zylberait D; Krulik M; Audebert AA; Debray J; Darnis F Sem Hop; 1979 Oct 8-15; 55(33-34):1473-8. PubMed ID: 229555 [TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis. Ambinder EP; Cohen LB; Wolke AM; Field SP; Adelsberg B; Schaffner F; Zaroulis CG J Clin Apher; 1985; 2(3):219-23. PubMed ID: 4030709 [TBL] [Abstract][Full Text] [Related]
17. Complement removal by sorbents in membrane plasmapheresis with on-line plasma treatment. Malchesky PS; Asanuma Y; Hammerschmidt DE; Nosé Y Trans Am Soc Artif Intern Organs; 1980; 26():541-5. PubMed ID: 7245545 [No Abstract] [Full Text] [Related]
18. [Primary biliary cirrhosis with scleroderma, Raynaud's syndrome, telangiectasis and thyroid disease]. Lichtenstein H; Poupon R; Bodin F; Conte-Marti J; Conte M Sem Hop; 1973 Feb; 49(8):555-9. PubMed ID: 4349575 [No Abstract] [Full Text] [Related]
19. [Primary biliary cirrhosis as seen by the rheumatologist. Apropos of 2 cases]. Thorel JB; Baron JJ; Dessauw P; Deshayes P Rev Rhum Mal Osteoartic; 1981 Apr; 48(4):341-6. PubMed ID: 7256143 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Babatin MA; Sanai FM; Swain MG Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]